No molecular drug target

The designation "No molecular drug target" is a descriptive placeholder used in drug discovery databases, such as ChEMBL, to categorize therapeutic agents that do not interact with a specific, identifiable molecular target like a protein or nucleic acid (ChEMBL Database, 2024). This often applies to drugs that function through non-specific physical or chemical mechanisms, including osmotic agents, chelating agents, or antacids that neutralize pH without binding to a receptor (StatPearls, 2023). In some instances, this label is assigned to drugs whose precise molecular mechanism of action remains unknown despite demonstrated clinical efficacy. Because this is a negative classification rather than a biological entity, it does not have associated molecular families, signaling pathways, or specific roles in disease pathology. For biotech analysts, this term indicates a lack of target-based pharmacology, requiring a focus on systemic or physicochemical effects rather than molecular binding kinetics. It serves as a critical administrative category for maintaining the integrity of pharmacological datasets when a traditional target-ligand relationship is absent.

Other names

Unknown targetNon-specific mechanismUnclassified targetNon-molecular target

Not applicable